MicroRNA-34a Inhibits Human Brain Glioma Cell Growth by Down-regulation of Notch1

Overview

Journal J Huazhong Univ Sci Technolog Med Sci

Specialty General Medicine

Date 2012 Jun 12

PMID 22684560

Citations 10

Authors

Xiao Yu

Wendi Zhang

Qin Ning

Xiaoping Luo

Affiliations

Soon will be listed here.

Abstract

The effects of microRNA-34a (miR-34a)-regulated Notch1 gene on the proliferation and apoptosis of the human glioma cell line U87 were investigated in this study. The U87 cells were divided into miR-34a mimics, negative control, mock transfection and blank control groups in terms of different treatments. In miR-34a mimics group, human U87 glioma cells were transfected with miR-34a mimics by using lipofectamine 2000. The cells transfected with nonsense microRNA were set up as negative control group. Those treated with lipofectamine 2000 only were designated to the mock tranfection group. In the blank control group, the cells were cultured routinely and no treatment was given. The expression of miR-34a and Notch1 was detected by using real-time RT-PCR. Western blotting was employed to monitor the change in Notch1 protein. Cell proliferation and apoptosis were measured by CCK-8 and flow cytometry. The results showed that the proliferative ability of U87 cells was significantly reduced and the apoptotic cells increased in miR-34a mimics group relative to control groups. The expression of miR-34a was significantly up-regulated in mimics group as compared with control groups (P<0.05). Furthermore, Notch1 protein levels were significantly decreased in miR-34a mimics group when compared with control groups (P<0.05), but the mRNA expression of Notch1 showed no significant difference among these groups. It was concluded that miR-34a may suppress the proliferation and induce apoptosis of U87 cells by decreasing the expression of target gene Notch1, suggesting that miR-34a may become a promising gene therapeutic target for brain glioma.

Citing Articles

A Critical Review on microRNAs as Prognostic Biomarkers in Laryngeal Carcinoma.

Komitova K, Dimitrov L, Stancheva G, Kyurkchiyan S, Petkova V, Dimitrov S Int J Mol Sci. 2025; 25(24.

PMID: 39769234 PMC: 11676902. DOI: 10.3390/ijms252413468.

GASC1 promotes glioma progression by enhancing NOTCH1 signaling.

Xiao Z, Yang X, Liu Z, Shao Z, Song C, Zhang K Mol Med Rep. 2021; 23(5).

PMID: 33649841 PMC: 7974312. DOI: 10.3892/mmr.2021.11949.

Melatonin inhibits proliferation and viability and promotes apoptosis in colorectal cancer cells via upregulation of the microRNA-34a/449a cluster.

Ji G, Zhou W, Li X, Du J, Li X, Hao H Mol Med Rep. 2021; 23(3).

PMID: 33398374 PMC: 7809902. DOI: 10.3892/mmr.2021.11826.

Spalt-Like Transcription Factor 1 (SALL1) Gene Expression Inhibits Cell Proliferation and Cell Migration of Human Glioma Cells Through the Wnt/β-Catenin Signaling Pathway.

Chi D, Zhang W, Jia Y, Cong D, Hu S Med Sci Monit Basic Res. 2019; 25:128-138.

PMID: 31040265 PMC: 6511114. DOI: 10.12659/MSMBR.915067.

Arctigenin, a natural lignan compound, induces G/G cell cycle arrest and apoptosis in human glioma cells.

Maimaitili A, Shu Z, Cheng X, Kaheerman K, Sikandeer A, Li W Oncol Lett. 2017; 13(2):1007-1013.

PMID: 28356992 PMC: 5351207. DOI: 10.3892/ol.2016.5474.

References

Milner L, Bigas A . Notch as a mediator of cell fate determination in hematopoiesis: evidence and speculation. Blood. 1999; 93(8):2431-48. View

Katoh M, Katoh M . Integrative genomic analyses on HES/HEY family: Notch-independent HES1, HES3 transcription in undifferentiated ES cells, and Notch-dependent HES1, HES5, HEY1, HEY2, HEYL transcription in fetal tissues, adult tissues, or cancer. Int J Oncol. 2007; 31(2):461-6. View

Ji Q, Hao X, Meng Y, Zhang M, DeSano J, Fan D . Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres. BMC Cancer. 2008; 8:266. PMC: 2564978. DOI: 10.1186/1471-2407-8-266. View

Monk C, Hutvagner G, Arthur J . Regulation of miRNA transcription in macrophages in response to Candida albicans. PLoS One. 2010; 5(10):e13669. PMC: 2965114. DOI: 10.1371/journal.pone.0013669. View

Betel D, Wilson M, Gabow A, Marks D, Sander C . The microRNA.org resource: targets and expression. Nucleic Acids Res. 2007; 36(Database issue):D149-53. PMC: 2238905. DOI: 10.1093/nar/gkm995. View

Hebert S, De Strooper B . Alterations of the microRNA network cause neurodegenerative disease. Trends Neurosci. 2009; 32(4):199-206. DOI: 10.1016/j.tins.2008.12.003. View

Wong J . MicroRNA-induced silencing of glioma progression. J Neurosci. 2010; 30(11):3868-9. PMC: 6632268. DOI: 10.1523/JNEUROSCI.0442-10.2010. View

Welch C, Chen Y, Stallings R . MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene. 2007; 26(34):5017-22. DOI: 10.1038/sj.onc.1210293. View

Fevre-Montange M, Champier J, Durand A, Wierinckx A, Honnorat J, Guyotat J . Microarray gene expression profiling in meningiomas: differential expression according to grade or histopathological subtype. Int J Oncol. 2009; 35(6):1395-407. DOI: 10.3892/ijo_00000457. View

10.

Inui M, Martello G, Piccolo S . MicroRNA control of signal transduction. Nat Rev Mol Cell Biol. 2010; 11(4):252-63. DOI: 10.1038/nrm2868. View

11.

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

12.

Yu J, Poulton J, Huang Y, Deng W . The hippo pathway promotes Notch signaling in regulation of cell differentiation, proliferation, and oocyte polarity. PLoS One. 2008; 3(3):e1761. PMC: 2258146. DOI: 10.1371/journal.pone.0001761. View

13.

Berezikov E, Guryev V, van de Belt J, Wienholds E, Plasterk R, Cuppen E . Phylogenetic shadowing and computational identification of human microRNA genes. Cell. 2005; 120(1):21-4. DOI: 10.1016/j.cell.2004.12.031. View

14.

Ji Q, Hao X, Zhang M, Tang W, Yang M, Li L . MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLoS One. 2009; 4(8):e6816. PMC: 2729376. DOI: 10.1371/journal.pone.0006816. View

15.

Fan X, Mikolaenko I, Elhassan I, Ni X, Wang Y, Ball D . Notch1 and notch2 have opposite effects on embryonal brain tumor growth. Cancer Res. 2004; 64(21):7787-93. DOI: 10.1158/0008-5472.CAN-04-1446. View

16.

Jiang L, Wu J, Chen Q, Hu X, Li W, Hu G . Notch1 expression is upregulated in glioma and is associated with tumor progression. J Clin Neurosci. 2011; 18(3):387-90. DOI: 10.1016/j.jocn.2010.07.131. View

17.

Chiocca E, Lawler S . The many functions of microRNAs in glioblastoma. World Neurosurg. 2010; 73(6):598-601. DOI: 10.1016/j.wneu.2010.06.047. View

18.

Wang Z, Ahmad A, Li Y, Azmi A, Miele L, Sarkar F . Targeting notch to eradicate pancreatic cancer stem cells for cancer therapy. Anticancer Res. 2011; 31(4):1105-13. View

19.

Zhang X, Zheng G, Zou L, Liu H, Hou L, Zhou P . Notch activation promotes cell proliferation and the formation of neural stem cell-like colonies in human glioma cells. Mol Cell Biochem. 2007; 307(1-2):101-8. DOI: 10.1007/s11010-007-9589-0. View

20.

Carthew R . Gene regulation by microRNAs. Curr Opin Genet Dev. 2006; 16(2):203-8. DOI: 10.1016/j.gde.2006.02.012. View